Provided by Tiger Fintech (Singapore) Pte. Ltd.

IQVIA

150.80
+0.52000.35%
Volume:120.60K
Turnover:18.21M
Market Cap:26.59B
PE:20.13
High:152.42
Open:151.28
Low:150.11
Close:150.28
Loading ...

Boasting A 23% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock?

Simply Wall St.
·
22 Mar

IQVIA Holdings (IQV) Fell on Lowered Guidance

Insider Monkey
·
21 Mar

IQVIA Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
21 Mar

Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific

Zacks
·
19 Mar

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
19 Mar

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 100% Above Its Share Price

Simply Wall St.
·
18 Mar

IQVIA Holdings Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
15 Mar

Mizuho Adjusts Price Target on IQVIA Holdings to $242 From $247, Maintains Outperform Rating

MT Newswires Live
·
14 Mar

IQVIA Holdings (NYSE:IQV) Secures Loan Refinancing To Reduce Interest Rate By 0.25% Points

Simply Wall St.
·
12 Mar

Argus Adjusts IQVIA Holdings Price Target to $245 From $260, Maintains Buy Rating

MT Newswires Live
·
11 Mar

IQVIA Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
11 Mar

IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services

Business Wire
·
10 Mar

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
08 Mar

IQVIA Gains From Diversified Client Base Despite Low Liquidity Woes

Zacks
·
08 Mar

ICON Public Limited Company (ICLR): A Bull Case Theory

Insider Monkey
·
07 Mar

IQVIA Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
06 Mar

TD Cowen Sticks to Its Buy Rating for IQVIA Holdings (IQV)

TIPRANKS
·
05 Mar

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

StockStory
·
05 Mar

IQVIA Holdings Is Maintained at Neutral by Citigroup

Dow Jones
·
05 Mar

BRIEF-Iqvia Laboratories Launches Site Lab Navigator With Breakthrough E-Requisition Innovation To Transform Clinical Trials

Reuters
·
04 Mar